Jazz Pharmaceuticals plc capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity: 1.20x
Net debt / equity: 0.79x
Debt / assets: 0.46x
Debt / EBITDA: 9.96x
Net debt / EBITDA: 6.57x

Liquidity & coverage

Current ratio: 2.04x
Quick ratio: 1.85x
Cash ratio: 1.28x
Interest coverage: 2.41x
EBITDA / interest: 2.66x
Working capital: $2.3B

Cash & dividend

FCF / debt: 0.23x
Cash flow / debt: 0.25x
Dividend per share: —
Dividend yield: —
Dividend growth 1y: —

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.